4 Healthcare Stock Stories for Tuesday Wellness

Hyperion Therapeutics (HPTX) Closing price $19.07

The firm reports that the FDA has okayed Ravicti for the treatment of urea cycle disorders  in patients two years of age and older. The medication should be commercially available by the end of April.


Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.